Lonza Group

Lonza Group

File:Lonza logo.svg

Type	Public
Traded as	SIX: LONN
Key people	Pierre-Alain Ruffieux (CEO)
Industry	Pharmaceuticals, Biotechnology
Products	Active pharmaceutical ingredients, Biopharmaceuticals, Specialty chemicals
Revenue	CHF 4.5 billion (2020)
Employees	15,000 (2020)
Website	[www.lonza.com Official website]

Lonza Group is a leading global provider of integrated healthcare solutions, specializing in the development, manufacturing, and supply of active pharmaceutical ingredients (APIs), biopharmaceuticals, and specialty chemicals. Founded in 1897 in the Swiss Alps, Lonza has grown to become a key player in the pharmaceutical and biotechnology industries, with a strong focus on innovation and sustainability.

History

Lonza was established in 1897 in the small Swiss town of Gampel, initially focusing on the production of electricity and calcium carbide. Over the years, the company expanded its operations and diversified its product offerings. In the mid-20th century, Lonza shifted its focus towards the chemical and pharmaceutical sectors, establishing itself as a leader in the production of fine chemicals and active pharmaceutical ingredients.

In the 21st century, Lonza has continued to grow through strategic acquisitions and partnerships, enhancing its capabilities in biopharmaceutical manufacturing and cell and gene therapy. The company is now headquartered in Basel, Switzerland, and operates globally with facilities in Europe, North America, and Asia.

Operations

Lonza operates through several business segments:

• Pharma & Biotech: This segment focuses on the development and manufacturing of APIs, biopharmaceuticals, and cell and gene therapies. Lonza provides end-to-end solutions for pharmaceutical companies, from early-stage development to commercial manufacturing.

• Specialty Ingredients: This segment offers a wide range of specialty chemicals used in various industries, including agrochemicals, coatings, and personal care products.

• Capsules & Health Ingredients: Lonza is a leading supplier of capsules and health ingredients, providing innovative solutions for the nutraceutical and pharmaceutical markets.

Research and Development

Lonza invests significantly in research and development to drive innovation and maintain its competitive edge. The company collaborates with academic institutions, research organizations, and industry partners to advance its technologies and develop new products. Key areas of focus include bioprocessing, cell and gene therapy, and sustainable chemistry.

Sustainability

Lonza is committed to sustainability and responsible business practices. The company has implemented various initiatives to reduce its environmental impact, including energy efficiency programs, waste reduction strategies, and sustainable sourcing of raw materials. Lonza also focuses on social responsibility, supporting community development and promoting diversity and inclusion within its workforce.

Also see

• Pharmaceutical industry
• Biotechnology
• Active pharmaceutical ingredient
• Biopharmaceutical
• Cell therapy
• Gene therapy

References

<references />

Template:Biotechnology companies